| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | -0.00071 | 1 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.00079 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00049 | 1 |